Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Shares Issued (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Shares Issued for 2 consecutive years, with $14.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued rose 3585006.6% to $14.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.4 million, a N/A change, with the full-year FY2025 number at $1.5 million, down 69.41% from a year prior.
  • Shares Issued was $14.7 million for Q4 2025 at Neuphoria Therapeutics, up from $3.3 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $14.7 million in Q4 2025 to a low of -$409.0 in Q4 2024.